Conference Proceedings

Cysteine-rich secretory protein 3 expression leads to invasive prostate cancer by modulating cell motility

Luc Furic, Marianna Volpert, Jinghua Hu, Anne O'Connor, Richard J Rebello, Shivakumar Keerthikumar, Jemma Evans, Jo Merriner, John Pedersen, Gail P Risbridger, Peter McIntyre, Moira K O'Bryan

CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2019

Abstract

Abstract Cysteine-rich secretory protein 3 (CRISP3) is one of the most highly up-regulated proteins during the transition from a healthy human prostatic epithelium to prostate cancer. The role of CRISP3 within this process has not however, been defined. Here we show using a genetically engineered mouse model of prostate cancer, that CRISP3 production greatly facilitates disease progression from carcinoma in situ to invasive prostate cancer in vivo. This observation was further validated using both human and mouse prostate cancer cell lines, which showed that exposure to CRISP3 enhanced cell motility and invasion. Further,using mass spectrometry, we showed that this activity..

View full abstract